2016
DOI: 10.1002/jnr.23914
|View full text |Cite
|
Sign up to set email alerts
|

Challenge of phenotype estimation for optimal treatment of Krabbe disease

Abstract: Krabbe disease is an autosomal recessive, inherited demyelinating disease caused by deficiency of the lysosomal enzyme galactocerebrosidase. It is recognized as one of the predominant genetic diseases showing leukodystrophy from infancy to adulthood. The clinical phenotype and genotype for this disease show considerable variation worldwide, which makes accurate diagnosis difficult. Effective therapy is limited, although hematopoietic stem cell transplantation at an early stage has been established to some exte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 36 publications
0
16
0
Order By: Relevance
“…We also wanted to draw attention to pattern B as indicative of KD in its later onset, as according to our clinical experience, it is not as well recognized by the clinician in comparison to pattern A. Especially with respect to therapeutic options, this seems of importance, as efficacy of HSCT is essentially related to early timing of this therapeutic intervention [19].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…We also wanted to draw attention to pattern B as indicative of KD in its later onset, as according to our clinical experience, it is not as well recognized by the clinician in comparison to pattern A. Especially with respect to therapeutic options, this seems of importance, as efficacy of HSCT is essentially related to early timing of this therapeutic intervention [19].…”
Section: Discussionmentioning
confidence: 99%
“…by Wenger et al [28], assume that more than 90% of Krabbe patients suffer from the early-infantile form, newer data by Duffner et al [5] indicate that 62% of the Krabbe patients show the early-infantile and 10% the late-infantile form; they describe, in addition 22% of patients with later onset and 5% with an adolescent/adult form. Slower progressive forms with a later onset are less well known and poorly systematically investigated, and may be underestimated [4,5,19].…”
Section: Background/introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Current descriptions of KD phenotype focus upon age of onset, distinguishing EIKD from later onset variants that can emerge in later infancy, childhood, or adulthood . But the age demarcations and symptomatic characterization of the later onset variants, as well as their relative proportions, are not defined unequivocally …”
Section: Introductionmentioning
confidence: 99%